Table 3

Clinical cardiovascular outcomes at 30 days and 6 months of follow-up (n=341)

Clinical outcomes	Low GRACE score group (n=229)	Intermediate-high GRACE score group (n=112)	P value
In-hospital mortality, n (%)	1 (0.4)	2 (1.8)	0.252
In-hospital stroke, n (%)	0 (0)	0 (0)	NA
At 30 days
Composite CV outcomes	5 (2.2)	13 (11.6)	0.001
Re-hospitalised with ACS	3 (1.3)	1 (0.9)	0.601
Re-hospitalised with HF	1 (0.4)	9 (8.0)	<0.001
Stroke	0 (0)	1 (0.9)	0.328
CV death	1 (0.4)	2 (1.8)	0.252
Non-CV death	0 (0)	0 (0)	NA
Loss to follow-up	0 (0)	0 (0)	NA
At 6 months (cumulative)
Composite CV outcomes*†	9 (3.9)	15 (13.4)	0.003
Re-hospitalised with ACS	6 (2.6)	1 (0.9)	0.433
Re-hospitalised with HF	2 (0.8)	10 (8.9)	<0.001
Stroke	0 (0)	2 (1.8)	0.107
CV death	1 (0.4)	2 (1.8)	0.252
Non-CV death	0 (0)	0 (0)	NA
Loss to follow-up	0 (0)	0 (0)	NA

Data presented as n (%).
*Crude hazard ratio for 6-month composite CV outcome was 5.02 (95% CI 2.47 to 10.20, p<0.001).
†Adjusted HR for 6-month composite CV outcome (adjusted by dyslipidaemia, angiographic findings and PCI performed) was 4.79 (95%CI 2.28 to 10.04, p<0.001).
ACS, acute coronary syndrome; CV, cardiovascular; GRACE, Global Registry for Acute Coronary Events; HF, heart failure; NA, not applicable.